Elizabeth Halloran
Associate Director of Evidence Synthesis
Expertise:
Elizabeth is an Associate Director of Evidence Synthesis at EVERSANA, with six years of experience conducting literature review and indirect treatment comparison projects. She has co-authored multiple publications and assisted in compiling evidence syntheses for health technology assessment submissions, across a variety of indications including gastroesophageal reflux disease, multiple sclerosis, and breast cancer. She holds a B.Sc. and M.Sc. in Chemical Biology from McMaster University. A list of Elizabeth’s publications can be found here.
Articles by Elizabeth Halloran
New Insights into Brain Volume Loss in MS
We are excited to announce that members of the EVERSANA team have contributed to a significant publication in BMC Neurology. The study, titled “Brain volume loss in relapsing multiple sclerosis: indirect treatment comparisons of available disease-modifying therapies,” provides valuable insights into the effects of various treatments on brain volume loss (BVL) in patients with relapsing multiple sclerosis. BVL may be associated with faster disability progression for patients with MS, therefore the finding of important differences in BVL rates between various disease-modifying treatments (DMTs) could have important implications for patients, clinicians and policymakers. Special recognition goes to our esteemed authors: from EVERSANA, along with their coauthors from the University of Buffalo, Janssen Scientific […]